(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
4 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 6.41%
-2.96% $ 1.310
Live Chart Being Loaded With Signals
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States...
Stats | |
---|---|
Dzisiejszy wolumen | 19 892.00 |
Średni wolumen | 49 327.00 |
Kapitalizacja rynkowa | 64.25M |
EPS | $0 ( 2024-02-15 ) |
Następna data zysków | ( $-0.0500 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -7.71 |
ATR14 | $0.0120 (0.91%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-09 | Obrien Geoffrey | Buy | 84 000 | Employee Stock Option (Right to Buy) |
2024-01-09 | Matsuda Kazuko | Buy | 157 500 | Employee Stock Option (Right to Buy) |
2024-01-09 | Iwaki Yuichi | Buy | 210 000 | Employee Stock Option (Right to Buy) |
2023-08-04 | Lemerond Nicole | Buy | 18 333 | Stock Option (Right to Buy) |
2023-08-04 | Lemerond Nicole | Buy | 0 |
INSIDER POWER |
---|
98.74 |
Last 93 transactions |
Buy: 6 161 551 | Sell: 1 269 768 |
MediciNova Inc Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje | |
---|---|
BNIXU | -0.808 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
MediciNova Inc Finanse
Annual | 2023 |
Przychody: | $1.00M |
Zysk brutto: | $979 705 (97.97 %) |
EPS: | $-0.170 |
FY | 2023 |
Przychody: | $1.00M |
Zysk brutto: | $979 705 (97.97 %) |
EPS: | $-0.170 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-212 426 (0.00 %) |
EPS: | $-0.290 |
FY | 2021 |
Przychody: | $4.04M |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.207 |
Financial Reports:
No articles found.
MediciNova Inc
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. Its product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic diseases, including nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. The company has collaboration agreements with Kissei Pharmaceutical Co., Ltd.; Kyorin Pharmaceutical Co., Ltd; Angiogene Pharmaceuticals Ltd.; and Meiji Seika Kaisha Ltd. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej